Genovis AB, a leading provider of innovative enzyme technologies, today announces a strategic partnership with Single Cell Discoveries to broaden the application of the SEQURNA® Thermostable RNase Inhibitor across advanced single-cell and bulk RNA-sequencing workflows.
The collaboration brings together Genovis’ expertise in developing high-performance molecular tools and Single Cell Discoveries’ extensive experience in RNA sequencing and transcriptomics. Through this partnership, the two companies will enable fast, sensitive RNA-sequencing readouts for the scientific community, supporting more complete Mechanisms of Action assays and higher-throughput target discovery for drug development.
Jotain eloa tähänkin putiikkiin.